Medicare Enrolled
Dr. Narine Arutyounian, M.D.
Family Medicine · Glendale, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Arutyounian from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Arutyounian?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Arutyounian
Dr. Narine Arutyounian is a family medicine specialist in Glendale, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Arutyounian performed 10,471 Medicare services across 5,404 unique beneficiaries.
Between the years covered by Open Payments, Dr. Arutyounian received a total of $91,008 from 52 pharmaceutical and/or device companies across 508 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Arutyounian is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 1% volume in CA
$91,008 industry payments
Medicare Practice Summary
Medicare Utilization ↗10,471
Medicare services
Top 1% in CA for family medicine
5,404
Unique beneficiaries
$76
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~551 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
2,434 | $100 | $200 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,429 | $106 | $200 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
983 | $8 | $20 |
| Blood glucose test using hand-held instrument A test that measures the level of sugar in the blood using a portable device. The result helps monitor blood glucose levels. |
729 | $3 | $20 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
492 | $73 | $150 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
478 | $66 | $120 |
| Hospital discharge management, 30+ min This service covers the care provided by a physician or qualified healthcare professional on the day a patient is discharged from the hospital. It requires more than 30 minutes of total time spent on the day of discharge. |
425 | $97 | $200 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
424 | $145 | $300 |
| Advance care planning consultation, first 30 min A session focused on discussing and documenting future healthcare preferences and goals. This service covers the initial 30 minutes of the planning discussion. |
403 | $87 | $200 |
| Annual alcohol misuse screening, 5 to 15 minutes | 399 | $21 | $100 |
| Annual depression screening | 397 | $21 | $100 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
322 | $140 | $200 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
227 | $177 | $300 |
| Telephone medical discussion, 21-30 minutes A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone. |
197 | $108 | $175 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
131 | $12 | $120 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
131 | $75 | $145 |
| Hospital discharge day management, 30 minutes or less This service covers the final day of hospital care when the patient is being discharged. It includes coordination of care and instructions for the patient within a time frame of 30 minutes or less. |
107 | $68 | $180 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
106 | $109 | $240 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
80 | $1 | $60 |
| Ketorolac injection, per 15 mg An injection of ketorolac tromethamine, a nonsteroidal anti-inflammatory drug, administered in doses measured per 15 mg. |
76 | $0 | $50 |
| Annual wellness visit, initial visit A yearly appointment to review your health and create a personalized prevention plan. This initial visit focuses on preventive care and health assessment. |
68 | $178 | $250 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
67 | $11 | $50 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
64 | $53 | $100 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
55 | $3 | $20 |
| Home health agency supervision, complex multidisciplinary care Supervision by a physician or allowed practitioner for a patient receiving Medicare-covered services from a participating home health agency. This involves complex and multidisciplinary care modalities, with the patient not present during the supervision. |
51 | $89 | $200 |
| Home health plan of care re-certification A physician reviews the patient's status and contacts the home health agency to re-certify the plan of care without the patient being present. |
40 | $36 | $80 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
39 | $33 | $40 |
| Flu vaccine, quadrivalent A flu shot containing four strains of the influenza virus to help prevent seasonal influenza infection. |
37 | $76 | $150 |
| Methylprednisolone injection, up to 40 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, administered in a dose of up to 40 mg. |
27 | $3 | $50 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
20 | $47 | $120 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
19 | $82 | $200 |
| Home health plan of care certification Certification by a physician or allowed practitioner for Medicare-covered home health services under a home health plan of care. This includes contacting the home health agency and reviewing reports of patient status required by physicians. |
14 | $46 | $100 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$91,008
Total received (2018-2024)
Avg $13,001/year across 7 years
Top 0% in CA for family medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
52
Companies
508
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$77,766 (85.4%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,105 (7.8%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$6,137 (6.7%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$4,333
2023
$13,479
2022
$16,088
2021
$5,877
2020
$681
2019
$22,471
2018
$28,077
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$3,361
Novo Nordisk Inc
$202
Amgen Inc.
$156
Edwards Lifesciences Corporation
$120
AstraZeneca Pharmaceuticals LP
$76
GlaxoSmithKline, LLC.
$64
VIVUS LLC
$62
Bayer Healthcare Pharmaceuticals Inc.
$62
SHIELD THERAPEUTICS INC
$47
Janssen Pharmaceuticals, Inc
$35
Ardelyx, Inc.
$31
Lundbeck LLC
$26
Sumitomo Pharma America, Inc.
$25
Novartis Pharmaceuticals Corporation
$24
Boehringer Ingelheim Pharmaceuticals, Inc.
$23
PFIZER INC.
$18
Top 3 companies account for 85.8% of 2024 payments
All-time payments by company (2018-2024) ›
Amarin Pharma Inc.
$25,436
Amgen Inc.
$21,642
Janssen Pharmaceuticals, Inc
$15,798
AbbVie Inc.
$8,050
ABBVIE INC.
$7,705
Celgene Corporation
$6,352
Novo Nordisk Inc
$858
Allergan, Inc.
$833
AstraZeneca Pharmaceuticals LP
$515
PFIZER INC.
$432
Abbott Laboratories
$312
Boston Scientific Corporation
$266
AbbVie, Inc.
$258
GlaxoSmithKline, LLC.
$247
Sunovion Pharmaceuticals Inc.
$213
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$170
Novartis Pharmaceuticals Corporation
$164
Bayer Healthcare Pharmaceuticals Inc.
$138
Edwards Lifesciences Corporation
$120
Vertiflex, Inc.
$116
Astellas Pharma US Inc
$109
Takeda Pharmaceuticals U.S.A., Inc.
$94
Lundbeck LLC
$79
Nestle HealthCare Nutrition Inc.
$75
Boehringer Ingelheim Pharmaceuticals, Inc.
$71
Biohaven Pharmaceuticals, Inc.
$63
VIVUS LLC
$62
Bayer HealthCare Pharmaceuticals Inc.
$59
Alnylam Pharmaceuticals Inc.
$58
Sumitomo Pharma America, Inc.
$52
Merck Sharp & Dohme LLC
$50
Otsuka America Pharmaceutical, Inc.
$50
SHIELD THERAPEUTICS INC
$47
ACADIA Pharmaceuticals Inc
$45
Esperion Therapeutics, Inc.
$45
E.R. Squibb & Sons, L.L.C.
$44
Allergan Inc.
$44
Horizon Therapeutics plc
$40
Ardelyx, Inc.
$31
SCILEX PHARMACEUTICALS INC.
$31
Adamas Pharmaceuticals, Inc.
$30
Teva Pharmaceuticals USA, Inc.
$26
Ironwood Pharmaceuticals, Inc
$22
RedHill Biopharma Inc.
$20
Smith & Nephew, Inc.
$20
Scilex Pharmaceuticals Inc.
$19
SANOFI-AVENTIS U.S. LLC
$18
Lilly USA, LLC
$17
Merck Sharp & Dohme Corporation
$16
Synergy Pharmaceuticals Inc
$16
Avanir Pharmaceuticals, Inc.
$14
Eisai Inc.
$12
Top 3 companies account for 69.1% of all-time payments
Associated products mentioned in payments ›
ACCRUFER · AIRSUPRA · AJOVY · ANORO · APRISO · Aemcolo · Aimovig · Amitiza · BELSOMRA · BREZTRI · BREZTRI AEROSPHERE · BYDUREON · CHANTIX · CREON · Creon · Dayvigo · ELIQUIS · ENTRESTO · EUCRISA · EVENITY · FARXIGA · GEMTESA · GIVLAARI · GOCOVRI · HUMALOG · IBSRELA · INVOKANA · JANUVIA · JARDIANCE · KRYSTEXXA · Kerendia · LINZESS · LONHALA MAGNAIR · LYRICA · MYRBETRIQ · NEXLETOL · NUEDEXTA · NUPLAZID · NURTEC ODT · Optisure Defibrillation ICD Lead · Otezla · Ozempic · PANCREAZE · PENNSAID · PREVNAR 13 · Prolia · QULIPTA · Quadra Allure MP RF CRT Pacemkr · Quadra Assura CRT Defibrillator · RESONATE · REXULTI · Repatha · Rybelsus · SAPIEN 3 Ultra RESILIA · SOLIQUA · Santyl · Superion ISS · TEZSPIRE · TRADJENTA · TRELEGY ELLIPTA · TRULANCE · Trintellix · Trulance · UBRELVY · UTIBRON · Uloric · VERQUVO · VRAYLAR · Vascepa · Victoza · XARELTO · XIFAXAN · ZENPEP · ZTLido · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (85%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in family medicine and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 0% for family medicine in CA.
Geographic Context
Family medicine physicians within 10 mi
3,224
Per 100K population
32.7
County median income
$87,760
Nearest hospital
GLENDALE MEM HOSPITAL & HLTH CENTER
0.9 mi
0.9 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Arutyounian is a clinical cardiology specialist, with above-average Medicare volume (top 1% in CA), with speaking/promotional industry engagement in the top 0% of CA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Arutyounian experienced with hospital follow-up visit, high complexity?
Based on Medicare claims data, Dr. Arutyounian performed 2,434 hospital follow-up visit, high complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Arutyounian receive payments from pharmaceutical companies?
Yes. Dr. Arutyounian received a total of $91,008 from 52 companies across 508 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Arutyounian's costs compare to other family medicine physicians in Glendale?
Dr. Arutyounian's average Medicare payment per service is $76. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Arutyounian) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Family Medicine
Common procedures, typical costs, and what industry payments mean in family medicine.
Same specialty & city
Family Medicine Physicians in Glendale
Browse family medicine physicians in Glendale ranked by procedure volume and transparency data.
Highest volume
Top Family Medicine Physicians in CA
Family medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Family Medicine Physicians in CA
Which CA family medicine physicians receive the most from drug and device companies.
By company
Amarin Pharma Inc. Payments to Doctors
See all physicians who received payments from Amarin Pharma Inc.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
Janssen Pharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Janssen Pharmaceuticals, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology